Simplex Trading’s SpringWorks Therapeutics SWTX Stock Holding History

Simplex Trading’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-46,435	Closed	-$2.07M	–	9708
2025 Q1	$2.05M	Buy	46,435 +38,020	+452%	+$1.75M	﹤0.01%	2011
2024 Q4	$304K	Sell	8,415 -14,659	-64%	-$512K	﹤0.01%	4055
2024 Q3	$739K	Buy	23,074 +1,981	+9%	+$74K	﹤0.01%	3212
2024 Q2	$794K	Sell	21,093 -2,498	-11%	-$105K	﹤0.01%	3160
2024 Q1	$1.16M	Buy	23,591 +20,330	+623%	+$940K	﹤0.01%	2960
2023 Q4	$119K	Buy	3,261 +2,794	+598%	+$72.9K	﹤0.01%	5213
2023 Q3	$10K	Buy	+467	New	+$12.8K	﹤0.01%	7198
2022 Q3	–	Sell	-5,531	Closed	-$159K	–	10863
2022 Q2	$136K	Buy	+5,531	New	+$202K	﹤0.01%	5143

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Simplex Trading's SWTX Position: Q2 2025 in Review

Simplex Trading sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 46,435 shares — an estimated $2.07M sold.

Simplex Trading first reported a position in SWTX in Q2 2022 and held it in 8 quarters. The position peaked at $2.05M in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

Simplex Trading reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
Simplex Trading sold 46,435 SpringWorks Therapeutics shares in Q2 2025, an estimated $2.07M.
Simplex Trading first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 8 quarters.
Simplex Trading's SpringWorks Therapeutics position peaked at $2.05M in Q1 2025.
223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.